Financial Technology

Financial Technology - INDUSTRY NEWS

Share

TMCNet:  Research and Markets: Chinese Markets for HIV Treatment Drugs - 2012 Report Presents Forecasts up to 2021

[January 16, 2013]

Research and Markets: Chinese Markets for HIV Treatment Drugs - 2012 Report Presents Forecasts up to 2021

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/w423t6/chinese_markets) has announced the addition of the "Chinese Markets for HIV Treatment Drugs" report to their offering.

China's demand for HIV treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

Chia has experienced over two decades of high economic growth, which has been stimulated by the consecutive increases of industrial output, consumer consumption and capital investment. China's GDP has been growing at 11% per annum. National industrial output has been advancing at 10.3% annually and will continue to sustain a strong growth into the next decade. The fast-growing middle class is creating an enormous consumer society. As the fastest-growing economy in the world, the emerging market has attracted the attention of investors and corporations around the world for the last two decades.

Story continues below ↓

To deepen the reform of state-owned enterprises is a long-term task and needs great efforts. The reform of state-owned economy has witnessed rapid changes in both economic and social aspects. The introduction of foreign advanced technology and capitals will continue to be favoured by the Chinese government and business community. New ways will be adopted to utilize foreign investment, including mergers, acquisition, and investment funds and securities investment.

Companies Mentioned:

Lianyunguang Dongfeng Pharmaceutical Factory

Beijing Greatwall Pharmaceutical Factory

Shanghai XiongQi Biological Products Co., Ltd.

Yongkang Pharmaceuticals Co., Ltd.

Beijing Sanjiu Wandong Pharmaceutical Co., Ltd.

Chinese Academy of Sciences Kunming Institute of Botany

Zhongda Qingtian Pharmaceuticals Co., Ltd.

Shantou Huatai Pharmaceutical Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/w423t6/chinese_markets


[ Back To Financial Technology's Homepage ]